A detailed history of Krilogy Financial LLC transactions in Incyte Corp stock. As of the latest transaction made, Krilogy Financial LLC holds 17,883 shares of INCY stock, worth $1.25 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
17,883
Previous 11,091 61.24%
Holding current value
$1.25 Million
Previous $671,000 81.37%
% of portfolio
0.08%
Previous 0.05%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 09, 2025

BUY
$55.17 - $71.22 $374,714 - $483,726
6,792 Added 61.24%
17,883 $1.22 Million
Q1 2025

Apr 16, 2025

BUY
$60.0 - $75.26 $665,460 - $834,708
11,091 New
11,091 $671,000
Q4 2018

Feb 14, 2019

SELL
$58.5 - $69.94 $17,550 - $20,982
-300 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$61.75 - $74.23 $18,525 - $22,269
300 New
300 $21,000
Q2 2018

Aug 15, 2018

SELL
$60.85 - $83.98 $37,118 - $51,227
-610 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$83.06 - $100.98 $8,306 - $10,098
-100 Reduced 14.08%
610 $51,000
Q2 2017

Aug 15, 2017

BUY
N/A
710
710 $89,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.